1887

Abstract

Preventing virally induced liver disease begins with an understanding of the host factors that define susceptibility to infection. Hepatitis C virus (HCV) is a global health issue, with an estimated 170 million infected individuals at risk of developing liver disease including fibrosis and hepatocellular carcinoma. The liver is the major reservoir supporting HCV replication and this hepatocellular tropism is defined by HCV engagement of cellular entry receptors. Hepatocytes are polarized in vivo and this barrier function limits HCV entry. We previously reported that activated macrophages promote HCV entry into polarized hepatocytes via a TNF-α-dependent process; however, the underlying mechanism was not defined. In this study, we show that several TNF superfamily members, including TNF-α, TNF-β, TWEAK and LIGHT, promote HCV entry via NF-κB-mediated activation of myosin light chain kinase (MLCK) and disruption of tight junctions. These observations support a model where HCV hijacks an inflammatory immune response to stimulate infection and uncovers a role for NF-κB-MLCK signalling in maintaining hepatocellular tight junctions.

Keyword(s): hepatitis C , MLCK , polarized entry and TNF
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000689
2017-04-01
2019-09-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/98/3/405.html?itemId=/content/journal/jgv/10.1099/jgv.0.000689&mimeType=html&fmt=ahah

References

  1. Meredith LW, Wilson GK, Fletcher NF, McKeating JA. Hepatitis C virus entry: beyond receptors. Rev Med Virol 2012;22:182–193 [CrossRef][PubMed]
    [Google Scholar]
  2. Ding Q, von Schaewen M, Ploss A. The impact of hepatitis C virus entry on viral tropism. Cell Host Microbe 2014;16:562–568 [CrossRef][PubMed]
    [Google Scholar]
  3. Harris HJ, Davis C, Mullins JG, Hu K, Goodall M et al. Claudin association with CD81 defines hepatitis C virus entry. J Biol Chem 2010;285:21092–21102 [CrossRef][PubMed]
    [Google Scholar]
  4. Farquhar MJ, Hu K, Harris HJ, Davis C, Brimacombe CL et al. Hepatitis C virus induces CD81 and claudin-1 endocytosis. J Virol 2012;86:4305–4316 [CrossRef][PubMed]
    [Google Scholar]
  5. Mee CJ, Harris HJ, Farquhar MJ, Wilson G, Reynolds G et al. Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells. J Virol 2009;83:6211–6221 [CrossRef][PubMed]
    [Google Scholar]
  6. Sourisseau M, Michta ML, Zony C, Israelow B, Hopcraft SE et al. Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies. PLoS Pathog 2013;9:e1003244 [CrossRef][PubMed]
    [Google Scholar]
  7. Mateo M, Generous A, Sinn PL, Cattaneo R. Connections matter — how viruses use cell–cell adhesion components. J Cell Sci 2015;128:431–439 [CrossRef][PubMed]
    [Google Scholar]
  8. Delorme-Axford E, Coyne CB. The actin cytoskeleton as a barrier to virus infection of polarized epithelial cells. Viruses 2011;3:2462–2477 [CrossRef][PubMed]
    [Google Scholar]
  9. Fletcher NF, Sutaria R, Jo J, Barnes A, Blahova M et al. Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner. Hepatology 2014;59:1320–1330 [CrossRef][PubMed]
    [Google Scholar]
  10. Feng G, Abdalla M, Li Y, Bai Y. NF-κB mediates the induction of Fas receptor and Fas ligand by microcystin-LR in HepG2 cells. Mol Cell Biochem 2011;352:209–219 [CrossRef][PubMed]
    [Google Scholar]
  11. Abou El Naga RN, Azab SS, El-Demerdash E, Shaarawy S, El-Merzabani M et al. Sensitization of TRAIL-induced apoptosis in human hepatocellular carcinoma HepG2 cells by phytochemicals. Life Sci 2013;92:555–561 [CrossRef][PubMed]
    [Google Scholar]
  12. Notas G, Alexaki VI, Kampa M, Pelekanou V, Charalampopoulos I et al. APRIL binding to BCMA activates a JNK2-FOXO3-GADD45 pathway and induces a G2/M cell growth arrest in liver cells. J Immunol 2012;189:4748–4758 [CrossRef][PubMed]
    [Google Scholar]
  13. Shiraki K, Sugimoto K, Okano H, Wagayama H, Fujikawa K et al. CD40 expression in HCV-associated chronic liver diseases. Int J Mol Med 2006;18:559–563 [CrossRef][PubMed]
    [Google Scholar]
  14. Decaens C, Durand M, Grosse B, Cassio D. Which in vitro models could be best used to study hepatocyte polarity?. Biol Cell 2008;100:387–398 [CrossRef][PubMed]
    [Google Scholar]
  15. Marion MJ, Hantz O, Durantel D. The HepaRG cell line: biological properties and relevance as a tool for cell biology, drug metabolism, and virology studies. Methods Mol Biol 2010;640:261–272 [CrossRef][PubMed]
    [Google Scholar]
  16. Fletcher NF, Humphreys E, Jennings E, Osburn W, Lissauer S et al. Hepatitis C virus infection of cholangiocarcinoma cell lines. J Gen Virol 2015;96:1380–1388 [CrossRef][PubMed]
    [Google Scholar]
  17. Godbersen JC, Humphries LA, Danilova OV, Kebbekus PE, Brown JR et al. The Nedd8-activating enzyme inhibitor MLN4924 thwarts microenvironment-driven NF-κB activation and induces apoptosis in chronic lymphocytic leukemia B cells. Clin Cancer Res 2014;20:1576–1589 [CrossRef][PubMed]
    [Google Scholar]
  18. Chang FM, Reyna SM, Granados JC, Wei SJ, Innis-Whitehouse W et al. Inhibition of neddylation represses lipopolysaccharide-induced proinflammatory cytokine production in macrophage cells. J Biol Chem 2012;287:35756–35767 [CrossRef][PubMed]
    [Google Scholar]
  19. Mathewson N, Toubai T, Kapeles S, Sun Y, Oravecz-Wilson K et al. Neddylation plays an important role in the regulation of murine and human dendritic cell function. Blood 2013;122:2062–2073 [CrossRef][PubMed]
    [Google Scholar]
  20. Cunningham KE, Turner JR. Myosin light chain kinase: pulling the strings of epithelial tight junction function. Ann N Y Acad Sci 2012;1258:34–42 [CrossRef][PubMed]
    [Google Scholar]
  21. Shen L. Tight junctions on the move: molecular mechanisms for epithelial barrier regulation. Ann N Y Acad Sci 2012;1258:9–18 [CrossRef][PubMed]
    [Google Scholar]
  22. Su L, Nalle SC, Shen L, Turner ES, Singh G et al. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. Gastroenterology 2013;145:407–415 [CrossRef][PubMed]
    [Google Scholar]
  23. Cerec V, Glaise D, Garnier D, Morosan S, Turlin B et al. Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor. Hepatology 2007;45:957–967 [CrossRef][PubMed]
    [Google Scholar]
  24. Negash AA, Ramos HJ, Crochet N, Lau DT, Doehle B et al. IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog 2013;9:e1003330 [CrossRef][PubMed]
    [Google Scholar]
  25. Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H et al. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 2009;457:882–886 [CrossRef][PubMed]
    [Google Scholar]
  26. Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003;3:745–756 [CrossRef][PubMed]
    [Google Scholar]
  27. Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 2007;446:801–805 [CrossRef][PubMed]
    [Google Scholar]
  28. Blaising J, Lévy PL, Gondeau C, Phelip C, Varbanov M et al. Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin-dependent trafficking. Cell Microbiol 2013;15:1866–1882 [CrossRef][PubMed]
    [Google Scholar]
  29. Greber UF. Virus and host mechanics support membrane penetration and cell entry. J Virol 2016;90:3802–3805 [CrossRef][PubMed]
    [Google Scholar]
  30. Burckhardt CJ, Suomalainen M, Schoenenberger P, Boucke K, Hemmi S et al. Drifting motions of the adenovirus receptor CAR and immobile integrins initiate virus uncoating and membrane lytic protein exposure. Cell Host Microbe 2011;10:105–117 [CrossRef][PubMed]
    [Google Scholar]
  31. Harris HJ, Clerte C, Farquhar MJ, Goodall M, Hu K et al. Hepatoma polarization limits CD81 and hepatitis C virus dynamics. Cell Microbiol 2013;15:430–445 [CrossRef][PubMed]
    [Google Scholar]
  32. Kotha PL, Sharma P, Kolawole AO, Yan R, Alghamri MS et al. Adenovirus entry from the apical surface of polarized epithelia is facilitated by the host innate immune response. PLoS Pathog 2015;11:e1004696 [CrossRef][PubMed]
    [Google Scholar]
  33. Gissen P, Arias IM. Structural and functional hepatocyte polarity and liver disease. J Hepatol 2015;63:1023–1037 [CrossRef][PubMed]
    [Google Scholar]
  34. Flint M, Logvinoff C, Rice CM, McKeating JA. Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins. J Virol 2004;78:6875–6882 [CrossRef][PubMed]
    [Google Scholar]
  35. Farquhar MJ, Harris HJ, Diskar M, Jones S, Mee CJ et al. Protein kinase A-dependent step(s) in hepatitis C virus entry and infectivity. J Virol 2008;82:8797–8811 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000689
Loading
/content/journal/jgv/10.1099/jgv.0.000689
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error